Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
Cancer02:18

Cancer

49.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Vaccines01:30

Cancer Vaccines

509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  2. 研究分野
  3. 生物医学と臨床科学
  4. 腫瘍学とがん発生
  5. 分子標的
  6. 薬の開発に関する現在の報告書は,がんの特徴の"新しい次元"に焦点を当てています.
  1. ホーム
  2. 研究分野
  3. 生物医学と臨床科学
  4. 腫瘍学とがん発生
  5. 分子標的
  6. 薬の開発に関する現在の報告書は,がんの特徴の"新しい次元"に焦点を当てています.

関連する実験動画

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.8K

薬の開発に関する現在の報告書は,がんの特徴の"新しい次元"に焦点を当てています.

Sisca Ucche1, Yonika Arum Larasati2, Dini Maharani3

  • 1Laboratory of Pharmacology and Toxicology, Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada Sekip Utara II, 55281 Yogyakarta, Indonesia.

Gene
|September 3, 2025

PubMed で要約を見る

まとめ
この要約は機械生成です。

新しいがん薬の発見は 細胞の可塑性や微生物群のような 新しい特徴をターゲットにしています これらの小さな分子は 癌の治療戦略と患者の治療結果を 改善することを目的としています

キーワード:
癌について薬の開発癌の新たな特徴治療法

さらに関連する動画

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.7K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

関連する実験動画

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.8K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.7K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

科学分野:

  • 腫瘍学
  • 薬理学について
  • 癌 生物学

背景:

  • がんは 世界的に大きな健康問題です
  • 癌の発達を理解するには 伝統的な特徴を超えて 新しい次元を探求する必要があります
  • フェノタイプの可塑性,老化,微生物群,および表遺伝的再プログラムが がんの新興の特徴です.

研究 の 目的:

  • 新しい癌の特徴を標的とした薬理学的薬剤をレビューする.
  • 新しいがん治療法の開発戦略を探求する
  • 癌治療の課題を克服する手助けをします

主な方法:

  • 小分子抗がん剤に関する文献のレビュー
  • フェノタイプ性可塑性 (脱差別化,ブロックされた差別化,トランス差別化) を対象とする剤の分析.
  • 老化細胞を標的とする薬物の分類 (老化剤と老化剤).
  • 化学療法効果に影響する微生物代謝物の検査
  • 非変異性エピジェネティック再プログラム (DNAメチル化阻害剤,ヒストン改変調節剤,BET阻害剤,クロマチン改変複合体) を標的とする薬物の分析.

主要な成果:

  • 小分子薬は,新しい次元の特徴をターゲットに,臨床前および臨床開発中です.
  • 特定の微生物代謝物は,化学療法効果に影響を与える可能性があります.
  • エピジェネティック・モディファイヤーは 有望な抗がん剤のクラスです
  • 結論:

    • 新しい癌の特徴をターゲットにすることで 新しい治療法が生まれます
    • フェノタイプの可塑性,老化,微生物群,および表遺伝学に対処する薬剤は,将来のがん治療戦略にとって極めて重要です.
    • このレビューは,がん患者の改善のための革新的なアプローチの開発に寄与します.